Results 71 to 80 of about 41,705 (223)
Anti-Enterovirus 71 Agents of Natural Products
Molecules, 2015 This review, with 42 references, presents the fascinating area of anti-enterovirus 71 natural products over the last three decades for the first time. It covers literature published from 2005–2015 and refers to compounds isolated from biogenic sources ...
Liyan Wang +4 more
doaj +1 more source
Cancer Reports, Volume 9, Issue 4, April 2026.ABSTRACT Background Infection is a significant cause of morbidity and mortality in pediatric oncology patients, especially during neutropenia. While bacterial infections are traditionally considered the primary cause of febrile neutropenia, the growing use of respiratory pathogen panels (RPPs) for viral detection in children has not been extensively ...
Farrah Gaston +3 more
wiley +1 more source
Sentinel surveillance for human enterovirus 71 in Sarawak, Malaysia: lessons from the first 7 years
BMC Public Health, 2006 Background A major outbreak of human enterovirus 71-associated hand, foot and mouth disease in Sarawak in 1997 marked the beginning of a series of outbreaks in the Asia Pacific region.
Yao Sik-King +13 more
doaj +1 more source
Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor [PDF]
, 2013 Enterovirus 71 (EV-71) infections are usually associated with mild hand, foot, and mouth disease in young children but have been reported to cause severe neurological complications with high mortality rates.
Chan, Yoke Fun +3 more
core +1 more source
Journal of Medical Virology, Volume 98, Issue 4, April 2026.ABSTRACT Severe rhinovirus (RV)/enterovirus (EV) respiratory infections in pediatric patients increased in the US during 2022–2023. This study aimed to characterize RV/EV genetic diversity among hospitalized children in Wisconsin and describe demographic and clinical factors of patients by RV/EV type.
Hannah L. Litwak +13 more
wiley +1 more source
Nano‐ and Micro‐Sized Solid Materials Used as Antiviral Agents
Advanced Functional Materials, Volume 36, Issue 26, 30 March 2026.Due to the rise of viral infections in humans and possible viral outbreaks, the use of nano‐ or micro‐sized materials as antiviral agents is rapidly increasing. This review explores their antiviral properties against RNA and DNA viruses, either as a prevention or a treatment tool, by delving into their mechanisms of action and how to properly assess ...
Orfeas‐Evangelos Plastiras +6 more
wiley +1 more source
Enterovirus 71 Maternal Antibodies in Infants, Taiwan
Emerging Infectious Diseases, 2009 Enterovirus 71 (EV71) causes life-threatening disease outbreaks in young children in Asia. This cohort study was conducted to understand the dynamics of maternal EV71 antibodies in Taiwanese young infants.
Shu-Ting Luo +6 more
doaj +1 more source
Neural precursor cells derived from induced pluripotent stem cells exhibit reduced susceptibility to infection with a neurotropic coronavirus. [PDF]
, 2017 The present study examines the susceptibility of mouse induced pluripotent stem cell-derived neural precursor cells (iPSC-NPCs) to infection with the neurotropic JHM strain of mouse hepatitis virus (JHMV).
Lane, Thomas E +4 more
core +1 more source
Acute Fulminant Cerebral Edema Caused by Coxsackievirus A6 Infection: A Case Report
Clinical Case Reports, Volume 14, Issue 3, March 2026.ABSTRACT In recent years, Coxsackievirus A6 (CV‐A6) has gradually replaced Enterovirus 71 (EV‐71) and Coxsackievirus A16 (CV‐A16) as the main pathogen causing hand foot mouth disease (HFMD) in China. This article reports a fatal case of HFMD caused by CV‐A6, leading to fulminant cerebral edema and cardiopulmonary arrest.
Kang An, Juan Qian
wiley +1 more source
Challenges to licensure of enterovirus 71 vaccines.
PLoS Neglected Tropical Diseases, 2012 Human enteroviruses usually cause self-limited infections except polioviruses and enterovirus 71 (EV71), which frequently involve neurological complications. EV71 vaccines are being evaluated in humans.
Min-Shi Lee +5 more
doaj +1 more source